(Q46619133)

23 December 2017

title

Relationships between human serum resistin, inflammatory markers and insulin resistance (English)

1 reference

23 December 2017

1 reference

1 reference

Bo S

1

1 reference

23 December 2017

Gambino R

2

1 reference

23 December 2017

Pagani A

3

1 reference

23 December 2017

Guidi S

4

1 reference

23 December 2017

Gentile L

5

1 reference

23 December 2017

Cassader M

6

1 reference

23 December 2017

Pagano GF

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

23 December 2017

International Journal of Obesity

published in

1 reference

23 December 2017

volume

29

1 reference

23 December 2017

issue

11

1 reference

23 December 2017

page(s)

1315-1320

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803037

exact match

0 references

cites work

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

The current biology of resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin, central obesity, and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin gene expression in human adipocytes is not related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin release by human adipose tissue explants in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Correlation between serum resistin level and adiposity in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Lipopolysaccharide increases resistin gene expression in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Modulation of resistin expression by retinoic acid and vitamin A status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Report of the expert committee on the diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

The irresistible biology of resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Serum resistin level in essential hypertension patients with different glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

An inflammatory cascade leading to hyperresistinemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Role of hyperglycemia in nitrotyrosine postprandial generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

inferred from DOI database lookup

7 January 2021

based on heuristic

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803037

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJO.0803037

1 reference

23 December 2017

Dimensions Publication ID

0 references

1 reference

23 December 2017